FDA warning letter · Drugs

Hangzhou Yiqi Biotechnology Co., Ltd

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure to demonstrate that your manufacturing process can reproducibly manufacture an API meeting its predetermined quality attributes.

Passage 2

Failure to validate and verify the suitability of analytical methods.

Passage 3

Failure to design a documented, ongoing stability testing program to monitor the stability characteristics of API and to use the results to confirm appropriate storage conditions and retest or expiry dates.

Passage 4

Failure to demonstrate that water used in the manufacture of your API is suitable for its intended use.